Krejsgaard Thorbjørn, Willerslev-Olsen Andreas, Lindahl Lise M, Bonefeld Charlotte M, Koralov Sergei B, Geisler Carsten, Wasik Mariusz A, Gniadecki Robert, Kilian Mogens, Iversen Lars, Woetmann Anders, Odum Niels
Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark;
Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark;
Blood. 2014 Jul 31;124(5):761-70. doi: 10.1182/blood-2014-01-551184. Epub 2014 Jun 23.
Patients with cutaneous T-cell lymphoma (CTCL) are frequently colonized with Staphylococcus aureus (SA). Eradication of SA is, importantly, associated with significant clinical improvement, suggesting that SA promotes the disease activity, but the underlying mechanisms remain poorly characterized. Here, we show that SA isolates from involved skin express staphylococcal enterotoxins (SEs) that induce crosstalk between malignant and benign T cells leading to Stat3-mediated interleukin-10 (IL-10) production by the malignant T cells. The SEs did not stimulate the malignant T cells directly. Instead, SEs triggered a cascade of events involving cell-cell and asymmetric cytokine interactions between malignant and benign T cells, which stimulated the malignant T cells to express high levels of IL-10. Much evidence supports that malignant activation of the Stat3/IL-10 axis plays a key role in driving the immune dysregulation and severe immunodeficiency that characteristically develops in CTCL patients. The present findings thereby establish a novel link between SEs and immune dysregulation in CTCL, strengthening the rationale for antibiotic treatment of colonized patients with severe or progressive disease.
皮肤T细胞淋巴瘤(CTCL)患者常被金黄色葡萄球菌(SA)定植。重要的是,根除SA与显著的临床改善相关,这表明SA促进疾病活动,但其潜在机制仍不清楚。在此,我们表明,从受累皮肤分离出的SA菌株表达葡萄球菌肠毒素(SEs),这些毒素可诱导恶性T细胞和良性T细胞之间的串扰,导致恶性T细胞产生Stat3介导的白细胞介素-10(IL-10)。SEs并不直接刺激恶性T细胞。相反,SEs引发了一系列事件,涉及恶性T细胞和良性T细胞之间的细胞间和不对称细胞因子相互作用,从而刺激恶性T细胞表达高水平的IL-10。许多证据支持,Stat3/IL-10轴的恶性激活在驱动CTCL患者典型出现的免疫失调和严重免疫缺陷中起关键作用。本研究结果因此在CTCL中建立了SEs与免疫失调之间的新联系,加强了对患有严重或进展性疾病的定植患者进行抗生素治疗的理论依据。